Abstract

The combination of computerized neuropsychological assessment and cerebrospinal fluid (CSF) biomarkers may improve the early diagnosis of Alzheimer's disease (AD) [Soldan et al., 2016]. Cambridge Neuropsychological Test Automated Battery (CANTAB) represents a computerized advanced tool for an in-depth neuropsychological evaluation. In CANTAB, the Paired Associates Learning (PAL) task (total errors and total errors 6-shapes), measuring visuo-spatial associative learning, is altered early in AD course [Junkkila et al., 2012]. We administered PAL in individuals with Subjective Cognitive Decline (SCD) [Jessen et al 2014] and Mild Cognitive Impairment (MCI) [Petersen et al., 2004] who underwent CSF AD biomarkers evaluation. We also explored the capacity of PAL in predicting cognitive decline over time. Seventy-two consecutive patients who referred to our Memory Clinic from 2012 to 2016 for memory complaints underwent a standard neuropsychological evaluation. Forty-one patients were classified as SCD (normal performance) and 31 as MCI (-1.5 SD in memory tests). The neuropsychological assessment also included CANTAB subtests assessing visual memory (pattern recognition memory, PRM), spatial working memory, SWM, and visuo-spatial associative learning, PAL. All patients underwent lumbar puncture to measure CSF AD biomarkers-Aβ1–42 (Aβ42), total tau (t-tau) and phosphorylated tau (p-tau). The neuropsychological assessment was repeated after 1 year. Out of 72 patients, 26 patients (39%) showed a CSF AD-like profile (16/31, 58%, MCI, 10/41, 24%, SCD). At follow-up, 8/41 (22%) of SCD progressed to MCI, where all but one showed an AD-like profile; 8/31 (25%) of MCI converted to dementia (5 to AD, 3 to other dementias). In SCD group, PAL-total errors fairly discriminated individuals with AD-like CSF profile with respect to those with normal CSF profile (-1.76±1.59 vs -0.65±1.44, p=0.048). Baseline performance on PAL-6 shapes was significantly associated with cognitive worsening as measured by MMSE. These results suggest that PAL test from CANTAB may be a sensitive and reliable neuropsychological measure to identify subjects with subtle cognitive deficits who may deserve CSF analysis for early AD detection.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.